An interventional study of Dietary in Night Eating Syndrome, Metabolic Syndrome and Cardiorenal Syndrome, sponsored by Koc University Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-26.
Sponsored by Koc University Hospital · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 54 studies in Metabolic Syndrome with a site in Turkey — 14 open to participants now, 16 under way, none of them phase 3. Metabolic Syndrome · Turkey.
Among the 54 studies in Metabolic Syndrome with a site in Turkey, this one is the 20th largest by enrollment of the 20 interventional ones that give a count, is one of 8 that started in 2022, is one of 16 with no phase, and was the 30th registered.
2,119 studies on the registry are indexed under Metabolic Syndrome; 350 are open to participants now.
Browse Metabolic Syndrome studies →14 of the 54 studies in Metabolic Syndrome with a site in Turkey are open now. Recruiting first, the newest first:
Karamanoğlu Mehmetbey University · Sites in Turkey
Ages 18+
Sisli Hamidiye Etfal Training and Research Hospital · Sites in Turkey
Ages 40–75
Abant Izzet Baysal University · Sites in Turkey
Ages 18–65
Yaşar Bayındır, MD · Sites in Turkey
Ages 18+ · Healthy volunteers
Istanbul University - Cerrahpasa · Sites in Turkey
Ages 18–50 · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 234 Metabolic Syndrome studies recruiting now, 70 (30%) set no upper age limit and 135 (58%) stop at 75 or younger; 20 take children under 18; 81 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
54 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 8 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 16 is below the median of 60 across 1,574 interventional studies indexed under Metabolic Syndrome.
Median enrollment 76 across the 20 interventional studies, 102 across the 34 observational. Of the 33 that completed or were terminated, 4 (12%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 54 have an industry lead sponsor. The 10 most frequent:
Koc University Hospital is the lead sponsor of 11 studies on the registry; 3 are open to participants now.
Koc University Hospital has 1 study filed under Metabolic Syndrome — fewer than ten, so there is no comparison to draw.
6 of the studies in Metabolic Syndrome with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07890155Sisli Hamidiye Etfal Training and Research HospitalEffect of Resistance Exercises on Serum IGF-1 Levels in Knee Osteoarthritis | 2026-12-01 |
| NCT07643376Toros UniversityEvaluation of Metabolic Parameters, Intestinal Permeability and Gastrointestinal Symptoms After Bariatric Surgery in Body Weight Management | 2027-01-01 |
| NCT07942415Recep Tayyip Erdogan University Training and Research HospitalStress Levels Periodontitis and Metabolic Syndrome | 2027-03-15 |
| NCT07731360Kayseri City HospitalNon-Invasive Diagnostic Panel for MASLD in Children With Obesity | 2027-04-01 |
| NCT07731373Kayseri City HospitalBiomarker Panel for PCOS-Associated Liver Steatosis in Adolescent Girls (COMPASS-pedPCOS) | 2027-04-30 |
Add all 6 to your calendar (.ics) → With an account.
Among the 54 studies in Metabolic Syndrome with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
In this study, the investigators are trying to find out of the effect of nighttime eating on metabolism, cardiorenal, hormonal and circadian rhythm, and a study was conducted to examine the effects of diseases that are quite common in internal medicine practice, such as type 2 diabetes mellitus, chronic kidney disease, hypertension, metabolic syndrome and sleep disorders.
The Coronavirus Disease (COVID)-19 pandemic, which emerged in recent years, has deeply affected living conditions and has had an impact on societies on eating habits. As shown by some studies, it has been shown that night sleep habits have changed and night nutrition and calorie intake have increased due to reasons related to staying at home, working remotely, and isolation during the pandemic period. However, some recent studies have shown a relationship between nighttime eating and conditions that predispose to metabolic syndrome, such as obesity and hyperglycemia. At the same time, prospective studies on the details of the cardiorenal and metabolic effects of night feeding behavior, which is one of the important predisposing factors for metabolic syndrome, are quite insufficient. Although the importance of nighttime eating habits has begun to be emphasized in recent years with recent randomized cross-controlled studies on this subject, there are not yet enough prospective studies on this subject. In this respect, studies on nighttime eating behavior, which is common in society, are important.In this study, a cross-over design study was conducted on the effectiveness of nighttime eating on metabolism, cardiorenal, hormonal and circadian rhythm, and a study was conducted to examine the effects of diseases that are quite common in internal medicine practice, such as type 2 diabetes mellitus, chronic kidney disease, hypertension, metabolic syndrome and sleep disorders. The investigators aim to create a new and additional perspective on the management, treatment and follow-up of common diseases and to contribute to raising awareness about night nutrition.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The diet of these healthy volunteers was such that no calories were consumed after 19.30 in the evening in the first week of the study.
Other: Dietary
The diet of the same healthy volunteers was 25% of the daily calorie need calculated according to the Harris - Benedict formula was taken, taking into account the night time eating syndrome (NES) criteria, after 20.30 in the evening.
Other: Dietary
The diet of these healthy volunteers was such that no calories were consumed after 19.30 in the evening in the first week, and in the second week, 25% of the daily calorie need calculated according to the Harris - Benedict formula was taken, taking into account the nighttime eating syndrome (NES) criteria, after 20.30 in the evening.
Change of the concentration albuminuria in the Nighttime Eating Period
More than 20% increase during night feeding period
Time frame: 1 week
Change of the concentration of serum melatonin levels in the Nighttime Eating Period
More than 50% increase during night feeding period
Time frame: 1 week
Change of the concentration of serum leptin levels in the Nighttime Eating Period
More than 50% increase during night feeding period
Time frame: 1 week
Change of the Concentration of serum ghrelin Levels in the Nighttime Eating Period
More than 50% increase during night feeding period
Time frame: 1 week
Change of the concentration of serum total cholesterol, low-density lipoprotein cholesterol, high density lipoprotein cholesterol and triglyceride levels in the Nighttime Eating Period
More than 20% increase during night feeding period
Time frame: 1 week
Change of Concentration of serum glucose in the Nighttime Eating Period
More than 10% increase during night feeding period
Time frame: 1 week
Change of Concentration of serum insulin in the Nighttime Eating Period
More than 10% increase during night feeding period
Time frame: 1 week
Change of concentration of serum Cortisol Level in the Nighttime Eating Period
More than 50% increase during night feeding period
Time frame: 1 week
Change of concentration of serum Fibroblast Growth Factor 21 Level in the Nighttime Eating Period
More than 10% increase during night feeding period
Time frame: 1 week
Change of the concentration of serum Cytokeratin 18 level in the Nighttime Eating Period
More than 10% increase during night feeding period
Time frame: 1 week
Change of value of Apnea Hypopnea Index in the Nighttime Eating Period
The Apnea-Hypopnea Index (AHI) is an index used to indicate the severity of sleep apnea. It is represented by the number of apnea and hypopnea events per hour of sleep. Apneas (pauses in breathing) must last for at least 10 seconds and be associated with a decrease in blood oxygenation to be considered. Combining AHI and oxygen desaturation gives an overall sleep apnea severity score that evaluates both the number of sleep breathing disruptions and the degree of oxygen desaturation (low oxygen level in the blood) during said disruptions. The AHI is calculated by dividing the number of apnea events by the number of hours of sleep. The AHI values for adults are categorized as: Normal: AHI\<5 Mild sleep apnea: 5≤AHI\<15 Moderate sleep apnea: 15≤AHI\<30 Severe sleep apnea: AHI≥30More than 10% increase during night feeding period
Time frame: 1 week
Plan to share: No
No publications or documents are linked to this record.
Ran from May 2022 to primary completion in Dec 2023, 19 months.
Of 627 non-industry interventional studies with no phase under Metabolic Syndrome, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 41. This study's 19 months is close to that.
Counting every sponsor, half of 677 studies reached it within 20 months; a quarter within 9 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Koc University Hospital